MedTrace Logo

Study of ABSORB Stent in Acute Myocardial Infarction

NCT02071342 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2014-02-25

No results posted yet for this study

Summary

The aim of our study is to evaluate the clinical outcomes at 30 days and 1 year (cardiac death, myocardial infarction, target lesion revascularization (TLR), target vessel revascularization (TVR), thrombosis of the device in patients who are undergoing angioplasty in myocardial infarction and in which bioabsorbable stent was implanted (BVS). Additionally, we will evaluate the acute recoil after implantation of bioabsorbable stents. A 24 months follow-up , by means of coronary angiography accompanied by QCA and assessment with intracoronary ultrasound (IVUS) and VH (virtual histology) is scheduled.

Conditions

  • Acute Myocardial Infarction
  • Artery; Deformity, Coronary (Acquired)

Interventions

PROCEDURE

angioplasty

patients with acute coronary syndrome and coronary angioplasty with bioresorbable vascular scaffold.

Sponsors & Collaborators

  • Umberto I Hospital, Frosinone Italy

    lead OTHER

Principal Investigators

  • Maurizio Menichelli, MD · Division of Cardiology "Fabrizio Spaziani" Hospital Frosinone, Italy

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2014-09-30
Completion
2015-09-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02071342 on ClinicalTrials.gov